Travere Therapeutics Ownership | Who Owns Travere Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Travere Therapeutics Ownership Summary


Travere Therapeutics is owned by 115.32% institutional investors, 0.78% insiders. Janus henderson group is the largest institutional shareholder, holding 12.80% of TVTX shares. Delaware Small Cap Core I is the top mutual fund, with 4.42% of its assets in Travere Therapeutics shares.

TVTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTravere Therapeutics115.32%0.78%-16.10%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group11.42M12.80%$339.25M
Blackrock7.64M9.86%$62.84M
Blackrock funding, inc. /de8.02M8.73%$455.65M
Fmr7.10M7.72%$403.16M
Vanguard group6.31M7.07%$241.08M
Bank of america corp /de/4.57M4.97%$259.53M
State street4.26M4.63%$241.80M
Vanguard capital management4.11M4.47%$233.41M
Perceptive advisors3.75M4.08%$213.18M
Macquarie management2.81M3.06%$159.78M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp2.00M6.28%$113.62M
Rock springs capital management lp2.18M6.04%$123.79M
Knott david m jr147.28K4.42%$8.37M
Palisades investment partners273.08K4.41%$15.51M
Bioimpact capital1.12M3.89%$63.78M
Artia global partners lp339.03K3.55%$19.26M
Perceptive advisors3.75M3.20%$213.18M
Eversept partners, lp798.97K2.35%$45.39M
Emerald advisers1.60M2.14%$90.95M
Emerald mutual fund advisers trust1.03M2.06%$58.63M

Top Buyers

HolderShares% AssetsChange
Bank of america corp /de/4.57M0.02%3.22M
Adage capital partners gp2.57M0.20%1.59M
Marshall wace, llp1.33M0.06%1.15M
Bnp paribas arbitrage, snc1.16M0.02%1.05M
Price t rowe associates inc /md/1.32M0.01%913.81K

Top Sellers

HolderShares% AssetsChange
Macquarie group---4.98M
Fmr7.10M0.02%-3.87M
Armistice capital1.57M1.09%-3.32M
Viking global investors lp---2.60M
Finepoint capital lp---1.78M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company827.28K0.01%827.28K$47.00M
Graham capital management446.70K0.46%446.70K$25.38M
Integral health asset management375.00K0.84%375.00K$21.30M
Capricorn fund managers321.72K1.44%321.72K$18.28M
Raymond james financial292.36K0.00%292.36K$16.61M

Sold Out

HolderChange
Wealthspire advisors-4.00
Bare financial services-12.00
Bell investment advisors-14.00
Nelson, van denburg & campbell wealth management group-14.00
Western wealth management-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202632817.56%105,942,4074.52%1150.95%20948.23%85-9.57%
Mar 31, 2026275-8.33%99,905,804-2.24%1110.85%140-16.67%92-6.12%
Dec 31, 2025123-52.69%33,249,544-66.99%370.29%78-43.48%36-52.00%
Sep 30, 202597-54.46%31,195,759-67.08%350.31%55-52.17%27-59.09%
Jun 30, 2025221-4.74%100,360,5602.40%1120.92%115-13.53%7120.34%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Delaware Small Cap Core I3.45M4.42%-21.39K
Macquarie Small Cap Core I3.36M3.77%-252.48K
Vanguard Total Stock Mkt Idx Inv2.95M3.17%1.88K
Vanguard Morn Total Stk Mkt Idx Investor2.95M3.17%1.88K
Aviva Investors GlConvtAbsRet I USD Acc2.20M2.88%-229.35K
Vanguard US Total Market Shares ETF2.51M2.82%-
Strategic Advisers Fidelity US TtlStk2.58M2.77%-1.72M
iShares Russell 2000 ETF2.26M2.40%-40.22K
State Street® SPDR® S&P® Biotech ETF2.09M2.22%4.81K
Nomura US Small Cap Core Equity1.78M1.92%-341.10K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 17, 2026LYONS GARY A-Sell$165.10K
Aug 17, 2026LYONS GARY A-Sell$32.08K
Aug 18, 2026LYONS GARY A-Sell$259.39K
Aug 17, 2026LYONS GARY A-Sell$118.80K
Aug 18, 2026LYONS GARY A-Sell$57.47K

Insider Transactions Trends


DateBuySell
2026 Q3-5
2026 Q2-40
2026 Q1-23
2025 Q4-12
2025 Q3-5

TVTX Ownership FAQ


Who Owns Travere Therapeutics?

Travere Therapeutics shareholders are primarily institutional investors at 115.32%, followed by 0.78% insiders and -16.10% retail investors. The average institutional ownership in Travere Therapeutics's industry, Biotech Stocks , is 49.09%, which Travere Therapeutics exceeds.

Who owns the most shares of Travere Therapeutics?

Travere Therapeutics’s largest shareholders are Janus henderson group (11.42M shares, 12.80%), Blackrock (7.64M shares, 9.86%), and Blackrock funding, inc. /de (8.02M shares, 8.73%). Together, they hold 31.40% of Travere Therapeutics’s total shares outstanding.

Does Blackrock own Travere Therapeutics?

Yes, BlackRock owns 9.86% of Travere Therapeutics, totaling 7.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 62.84M$. In the last quarter, BlackRock decreased its holdings by -152K shares, a -1.95% change.

Who is Travere Therapeutics’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Travere Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.28% of its assets in 2M Travere Therapeutics shares, valued at 113.62M$.

Who is the top mutual fund holder of Travere Therapeutics shares?

Delaware Small Cap Core I is the top mutual fund holder of Travere Therapeutics shares, with 4.42% of its total shares outstanding invested in 3.45M Travere Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools